Conestoga Capital Advisors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 283 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 6.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
Conestoga Capital Advisors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$57,829,000
-23.5%
440,802
-11.1%
0.84%
-26.7%
Q1 2021$75,597,000
+6.1%
495,881
-30.8%
1.14%
+0.3%
Q4 2020$71,250,000
+5.4%
716,440
+1.0%
1.14%
-16.7%
Q3 2020$67,620,000
-10.1%
709,398
+5.4%
1.36%
-16.7%
Q2 2020$75,249,000
+59.5%
672,768
+3.7%
1.64%
+18.7%
Q1 2020$47,166,000
-27.0%
648,603
+4.7%
1.38%
-11.3%
Q4 2019$64,624,000
+2.6%
619,653
-2.1%
1.56%
-3.5%
Q3 2019$62,978,000
-13.3%
632,694
-0.6%
1.61%
-11.2%
Q2 2019$72,679,000
-6.9%
636,699
+2.5%
1.82%
-16.4%
Q1 2019$78,067,000
+18.2%
621,006
+27.6%
2.17%
+3.2%
Q4 2018$66,063,000
-57.5%
486,833
-14.0%
2.10%
-46.9%
Q3 2018$155,423,000
+49.5%
566,223
+12.8%
3.97%
+18.5%
Q2 2018$103,977,000
+33.8%
501,894
+6.7%
3.35%
+12.5%
Q1 2018$77,713,000
+15.9%
470,530
-3.9%
2.98%
+15.6%
Q4 2017$67,072,000
+13.7%
489,830
+13.1%
2.58%
-1.3%
Q3 2017$58,970,000
+25.9%
433,125
+12.2%
2.61%
+7.0%
Q2 2017$46,844,000
+22.7%
385,869
+7.0%
2.44%
+5.6%
Q1 2017$38,184,000
+10.2%
360,774
+5.8%
2.31%
+0.0%
Q4 2016$34,651,000
+0.0%
341,022
+0.5%
2.31%
-2.8%
Q3 2016$34,646,000
-7.6%
339,467
+8.0%
2.37%
-14.3%
Q2 2016$37,480,000
-15.3%
314,247
-24.0%
2.77%
-7.4%
Q1 2016$44,267,000
+42.7%
413,362
+44.5%
2.99%
+19.2%
Q4 2015$31,026,000
+17.3%
286,162
-7.3%
2.51%
+18.3%
Q3 2015$26,444,000
-18.1%
308,750
-3.6%
2.12%
-5.4%
Q2 2015$32,302,000
+28.7%
320,141
-1.6%
2.24%
+30.5%
Q1 2015$25,097,000
+42.9%
325,471
-1.4%
1.72%
+40.6%
Q4 2014$17,563,000
+27.5%
330,066
+12.6%
1.22%
+21.5%
Q3 2014$13,771,000
-9.4%
293,057
+20.1%
1.01%
-1.4%
Q2 2014$15,197,000243,9671.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders